K Number
K972699
Date Cleared
1997-12-19

(154 days)

Product Code
Regulation Number
876.1500
Reference & Predicate Devices
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The AESOP 3000 System is intended to be used as a robotic, computer-driven system whose function is to hold and position a rigid laparoscope/endoscope. The AESOP 3000 System is indicated for use in general thoracoscopy, general cardiothoracic surgery, general laparoscopy, nasopharyngoscopy, ear endoscopy, and sinuscopy where a rigid laparoscope/endoscope is indicated for use. A few examples of the more common endoscopic surgeries are laparoscopic cholecystectomy, laparoscopic hernia repair, laparoscopic appendectomy, laparoscopic pelvic lymph node dissection, laparoscopically assisted hysterectorny, laparoscopic anterior spinal fusion, decompression fixation, wedge resection, lung biopsy, pleural biopsy, dorsal sympathectorny, pleurodesis, internal mammary artery dissection for coronary artery bypass, coronary artery bypass grafting where endoscopic visualization is indicated and examination of the evacuated cardiac chamber during performance of valve replacement. The users of the AESOP 3000 System are general surgeons, gynecologists, cardiac surgeons, thoracic surgeons, plastic surgeons, orthopedic surgeons, ENT surgeons and urologists.

Device Description

The AESOP 3000 System is a robotic computer-driven system whose basic function is to hold and position a laparoscope/endoscope under the direct control of a surgeon.

AI/ML Overview

The AESOP 3000 System is a robotic, computer-driven system whose basic function is to hold and position a laparoscope/endoscope under the direct control of a surgeon. The device's acceptance criteria are based on compliance with various international and national standards for medical electrical equipment and reprocessing of medical devices, as well as internal functional test requirements.

Here's a breakdown of the requested information:

1. Table of Acceptance Criteria and Reported Device Performance:

Acceptance Criteria CategorySpecific Standard/RequirementReported Device Performance
International StandardsIEC 601-1 Second Edition 1988Device designed and tested to this standard.
IEC 601-1 Amendment 1 1991Device designed and tested to this standard.
IEC 601-2-18 First Edition 1990Device designed and tested to this standard.
National StandardsUL 2601-1Device designed and tested to this standard.
AMMI TIR 12Device designed and tested to this standard.
CAN/CSA-C22.2 NO. 601.1-M90 & NO. 601.2.18-92Device designed and tested to this standard.
European Union DirectiveEMC Directive 89/336/EECDevice designed and tested to this directive.
Internal RequirementsAESOP 3000 System Functional Test RequirementsDevice designed and tested to these requirements.

2. Sample Size Used for the Test Set and Data Provenance:

The provided document does not specify a separate "test set" in the context of a clinical performance study with human subjects or a dataset for AI validation. The device's performance is primarily established through compliance with engineering and safety standards, and functional testing. Therefore, information regarding sample size, country of origin, or retrospective/prospective nature for a test set in the conventional sense is not available in this filing.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications:

As the acceptance criteria are based on compliance with engineering, safety, and functional standards rather than diagnostic accuracy or clinical outcomes evaluation in a traditional sense, the concept of "experts to establish ground truth" also does not directly apply in the context of this 510(k) summary. The experts involved would likely be engineers, quality assurance personnel, and regulatory affairs specialists who ensured the device met the specified technical and safety standards. Their qualifications are not detailed in this summary.

4. Adjudication Method for the Test Set:

Given the nature of the acceptance criteria (compliance with standards and functional testing), an "adjudication method" as typically used for clinical endpoints or diagnostic accuracy (e.g., 2+1, 3+1) is not applicable to this submission. Evaluation would involve engineering verification and validation processes against the specified standards and functional requirements.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study:

Based on the provided document, there is no mention of an MRMC comparative effectiveness study being conducted or its results. The AESOP 3000 System is a robotic tool that assists surgeons in positioning an endoscope, not a diagnostic imaging device that requires interpretation by multiple readers. Therefore, the effect size of human readers improving with AI vs. without AI assistance is not relevant or reported here.

6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study:

The AESOP 3000 System is explicitly described as a "robotic computer-driven system whose basic function is to hold and position a laparoscope/endoscope under the direct control of a surgeon." This means it is inherently a human-in-the-loop device. Therefore, a standalone (algorithm only) performance study does not apply to this device's function or evaluation as described in the 510(k) summary.

7. Type of Ground Truth Used:

The "ground truth" for the AESOP 3000 System's acceptance is based on its technical specifications, functional requirements, and compliance with established industry and international safety standards. This is not ground truth in the sense of a medical diagnosis (e.g., pathology, outcomes data, or expert consensus on disease presence). Rather, it's about verifying that the robotic arm moves as intended, responds to surgeon controls, and meets safety parameters.

8. Sample Size for the Training Set:

Since the AESOP 3000 System is a robotic surgical assistant and not an AI/ML diagnostic tool, the concept of a "training set" for machine learning algorithms is not applicable in the context of this 510(k) summary. The device's operation is dictated by its programmed mechanics and controls, not by learning from a training dataset.

9. How the Ground Truth for the Training Set Was Established:

As there is no mention of a "training set" for machine learning, the establishment of ground truth for such a set is not relevant or described in this document.

{0}------------------------------------------------

AESOP 3000 System 510(k) Summary

In accordance with 21 CFR section 807.92 Computer Motion is submitting the following safety and effectiveness summary.

  1. Submitter Information

Computer Motion. Inc. 130-B Cremona Drive Goleta, CA 93117 805-685-3729 Contact: Douglas Bueschel Prepared: July 17, 1997

DEC 1 9 1997 K972699

  1. Name of Device

Proprietary Name: AESOP 3000 System and Accessories Common Name: Automated Endoscopic System for Optimal Positioning Classification Name: Laparoscope, General & Plastic Surgery

  1. Substantially equivalent to AESOP 510(k)'s K931783, K960655 and K963126.

  2. The AESOP 3000 System is a robotic computer-driven system whose basic function is to hold and position a laparoscope/endoscope under the direct control of a surgeon.

The intended use of the AESOP 3000 System is a robotic computer driven system whose function is to hold and position a rigid laparoscope/endoscope . The AESOP 3000 System is indicated for use in general thoracoscopy, general cardiothoracic surgery, general laparoscopy, nasopharyngoscopy, ear endoscopy, and sinuscopy where a rigid laparoscope/endoscope is indicated for use. A few examples of the more common endoscopic surgeries are laparoscopic cholecystectorny, laparoscopic hernia repair, laparoscopic appendectomy, laparoscopic pelvic lymph node dissection, laparoscopically assisted hysterectomy, laparoscopic & thorascopic anterior spinal fusion, decompression fixation, wedge resection, lung biopsy, pleural biopsy, dorsal sympathectomy, pleurodesis, internal mammary artery dissection for coronary artery bypass, coronary artery bypass grafting where endoscopic visualization is indicated and examination of the evacuated cardiac chamber during performance of valve replacement. The users of the AESOP 3000 System are general surgeons, gynecologists, cardiac surgeons, thoracic surgeons, plastic surgeons, orthopedic surgeons, ENT surgeons and urologists.

  1. The AESOP 3000 System is designed and tested to the following Computer Motion and voluntary standards.
  • IEC 601-1 Second Edition 1988 International Standard for Medical Electrical Equipment .
  • IEC 601-1 Amendment 1 1991 International Standard for Medical Electrical Equipment .
  • IEC 601-2-18 First Edition 1990 International Standard for Medical Electrical Equipment .
  • . UL 2601-1
  • AMMI TIR 12 Design, Testing, and Labeling Reusable Medical Devices for Reprocessing in . Healthcare Facilities
  • . EMC Directive European Union 89/336/EEC
  • CAN/CSA-C22.2 NO. 601.1-M90 & NO. 601.2.18-92 ●
  • AESOP 3000 System Functional Test Requirements

{1}------------------------------------------------

Image /page/1/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features the department's emblem, which consists of a stylized human figure with three faces in profile, representing the department's focus on people. The emblem is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" in a circular arrangement.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

DEC 19 1997

Mr. Douglas P. Bueschel Director, Regulatory Affairs & Quality Assurance Computer Motion, Incorporated 130-B Cremona Drive Goleta, California 93117

K972699 Re:

Trade Name: "AESOP 3000 System and Accessories" Regulatory Class: II Product Code: GCJ Dated: October 21, 1997 Received: October 22, 1997

Dear Mr. Bueschel:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirements , as set forth in the Quality System Regulation (OS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does

{2}------------------------------------------------

Page 2 - Mr. Bueschel

not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely vours.

Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

AESOP 3000 System 510(k) Summary

In accordance with 21 CFR section 807.92 Computer Motion is submitting the following safety and effectiveness summary.

  1. Submitter Information

Computer Motion. Inc. 130-B Cremona Drive Goleta, CA 93117 805-685-3729 Contact: Douglas Bueschel Prepared: July 17, 1997

DEC 1 9 1997 K972699

  1. Name of Device

Proprietary Name: AESOP 3000 System and Accessories Common Name: Automated Endoscopic System for Optimal Positioning Classification Name: Laparoscope, General & Plastic Surgery

  1. Substantially equivalent to AESOP 510(k)'s K931783, K960655 and K963126.

  2. The AESOP 3000 System is a robotic computer-driven system whose basic function is to hold and position a laparoscope/endoscope under the direct control of a surgeon.

The intended use of the AESOP 3000 System is a robotic computer driven system whose function is to hold and position a rigid laparoscope/endoscope . The AESOP 3000 System is indicated for use in general thoracoscopy, general cardiothoracic surgery, general laparoscopy, nasopharyngoscopy, ear endoscopy, and sinuscopy where a rigid laparoscope/endoscope is indicated for use. A few examples of the more common endoscopic surgeries are laparoscopic cholecystectorny, laparoscopic hernia repair, laparoscopic appendectomy, laparoscopic pelvic lymph node dissection, laparoscopically assisted hysterectomy, laparoscopic & thorascopic anterior spinal fusion, decompression fixation, wedge resection, lung biopsy, pleural biopsy, dorsal sympathectomy, pleurodesis, internal mammary artery dissection for coronary artery bypass, coronary artery bypass grafting where endoscopic visualization is indicated and examination of the evacuated cardiac chamber during performance of valve replacement. The users of the AESOP 3000 System are general surgeons, gynecologists, cardiac surgeons, thoracic surgeons, plastic surgeons, orthopedic surgeons, ENT surgeons and urologists.

  1. The AESOP 3000 System is designed and tested to the following Computer Motion and voluntary standards.
  • IEC 601-1 Second Edition 1988 International Standard for Medical Electrical Equipment .
  • IEC 601-1 Amendment 1 1991 International Standard for Medical Electrical Equipment .
  • IEC 601-2-18 First Edition 1990 International Standard for Medical Electrical Equipment .
  • . UL 2601-1
  • AMMI TIR 12 Design, Testing, and Labeling Reusable Medical Devices for Reprocessing in . Healthcare Facilities
  • . EMC Directive European Union 89/336/EEC
  • CAN/CSA-C22.2 NO. 601.1-M90 & NO. 601.2.18-92 ●
  • AESOP 3000 System Functional Test Requirements

{4}------------------------------------------------

Image /page/4/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features the department's emblem, which consists of a stylized human figure with three faces in profile, representing the department's focus on people. The emblem is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" in a circular arrangement.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

DEC 19 1997

Mr. Douglas P. Bueschel Director, Regulatory Affairs & Quality Assurance Computer Motion, Incorporated 130-B Cremona Drive Goleta, California 93117

K972699 Re:

Trade Name: "AESOP 3000 System and Accessories" Regulatory Class: II Product Code: GCJ Dated: October 21, 1997 Received: October 22, 1997

Dear Mr. Bueschel:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirements , as set forth in the Quality System Regulation (OS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does

{5}------------------------------------------------

Page 2 - Mr. Bueschel

not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely vours.

Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{6}------------------------------------------------

3. Intended Use and Indications for Use

3.1. Intended Use

The AESOP 3000 System is intended to be used as a robotic, computer-driven system whose function is to hold and position a rigid laparoscope/endoscope .

3.2. Indications For Use

The AESOP 3000 System is indicated for use in general thoracoscopy, general cardiothoracic surgery, general laparoscopy, nasopharyngoscopy, ear endoscopy, and sinuscopy where a rigid laparoscope/endoscope is indicated for use. A few examples of the more common endoscopic surgeries are laparoscopic cholecystectomy, laparoscopic hernia repair, laparoscopic appendectomy, laparoscopic pelvic lymph node dissection, laparoscopically assisted hysterectorny, laparoscopic anterior spinal fusion, decompression fixation, wedge resection, lung biopsy, pleural biopsy, dorsal sympathectorny, pleurodesis, internal mammary artery dissection for coronary artery bypass, coronary artery bypass grafting where endoscopic visualization is indicated and examination of the evacuated cardiac chamber during performance of valve replacement. The users of the AESOP 3000 System are general surgeons, gynecologists, cardiac surgeons, thoracic surgeons, plastic surgeons, orthopedic surgeons, ENT surgeons and urologists.

Prescription Use
(Per 21 CFR 801.109)

(Division Sign-Off)
Division of General Restorative Devices
510(k) Number K972699

§ 876.1500 Endoscope and accessories.

(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.